The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Chloro-8-oxa-tricyclo[7.3.1.0*2,7*]trideca-2(7),3,5-triene-6-carboxylic acid (1-aza-bicyclo[2.2.2]oct-3-yl)-amide ID: ALA171518
Cas Number: 143170-09-6
PubChem CID: 15171287
Max Phase: Preclinical
Molecular Formula: C20H25ClN2O2
Molecular Weight: 360.89
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NC1CN2CCC1CC2)c1cc(Cl)cc2c1OC1CCCC2C1
Standard InChI: InChI=1S/C20H25ClN2O2/c21-14-9-16-13-2-1-3-15(8-13)25-19(16)17(10-14)20(24)22-18-11-23-6-4-12(18)5-7-23/h9-10,12-13,15,18H,1-8,11H2,(H,22,24)
Standard InChI Key: ZIAMDRHEQRSMSY-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 29 0 0 0 0 0 0 0 0999 V2000
2.3000 -1.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3000 -2.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0125 -1.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5875 -2.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0125 -2.9542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7292 -1.7042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4417 -1.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5792 -3.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8667 -1.2917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5792 -1.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1542 -1.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8667 -2.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0042 -0.4750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4375 -0.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2917 -4.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0042 -3.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8667 -1.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1542 -0.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8417 -1.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8667 -0.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5542 -0.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1542 -1.3042 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.5667 -4.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2875 -5.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0042 -4.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 2 2 0
5 2 1 0
6 3 1 0
7 6 1 0
8 4 1 0
9 11 1 0
10 1 2 0
11 7 1 0
12 17 2 0
13 3 2 0
14 7 1 0
15 16 1 0
16 5 1 0
17 10 1 0
18 14 1 0
19 14 1 0
20 18 1 0
21 19 1 0
22 17 1 0
23 8 1 0
24 25 1 0
25 16 1 0
12 4 1 0
8 15 1 0
24 23 1 0
21 9 1 0
9 20 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 360.89Molecular Weight (Monoisotopic): 360.1605AlogP: 3.58#Rotatable Bonds: 2Polar Surface Area: 41.57Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.84CX Basic pKa: 7.75CX LogP: 3.12CX LogD: 2.61Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.88Np Likeness Score: 0.15
References 1. Youssefyeh RD, Campbell HF, Airey JE, Klein S, Schnapper M, Powers M, Woodward R, Rodriguez W, Golec S, Studt W.. (1992) Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides., 35 (5): [PMID:1548679 ] [10.1021/jm00083a015 ]